We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.6B
AUM Growth
+$2.17B
Cap. Flow
-$81M
Cap. Flow %
-0.49%
Top 10 Hldgs %
31.47%
Holding
166
New
39
Increased
28
Reduced
33
Closed
30

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$366M
2
XLNX
Xilinx Inc
XLNX
+$332M
3
RTX icon
RTX Corp
RTX
+$299M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$289M
5
AVGO icon
Broadcom
AVGO
+$243M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$498M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$299M
3
ABBV icon
AbbVie
ABBV
+$298M
4
PANW icon
Palo Alto Networks
PANW
+$217M
5
BMY icon
Bristol-Myers Squibb
BMY
+$215M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Communication Services 13.23%
3 Financials 10.05%
4 Technology 9.85%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
126
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-1,000,000
Closed -$14.7M
CI icon
127
Cigna
CI
$74.6B
– –
-502,231
Closed -$85.1M
CMPS
128
Compass Pathways
CMPS
$1.83B
– –
-362,940
Closed -$12.7M
CRDF icon
129
Cardiff Oncology
CRDF
$77.2M
– –
-200,000
Closed -$2.84M
DYN icon
130
Dyne Therapeutics
DYN
$4.9B
– –
-200,000
Closed -$4.04M
EMB icon
131
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
– –
-288,900
Closed -$320M
EQIX icon
132
Equinix
EQIX
$103B
– –
-200,164
Closed -$152M
GD icon
133
General Dynamics
GD
$106B
– –
-1,277,107
Closed -$177M
LQDA icon
134
Liquidia Corp
LQDA
$8.02B
– –
-1,865,350
Closed -$9.18M
NVCR icon
135
NovoCure
NVCR
$1.91B
– –
-725,000
Closed -$80.7M
PANW icon
136
Palo Alto Networks
PANW
$297B
– –
-5,327,352
Closed -$217M
RCUS icon
137
Arcus Biosciences
RCUS
$3.64B
– –
-550,000
Closed -$9.43M
TARA icon
138
Protara Therapeutics
TARA
$232M
– –
-425,000
Closed -$7.15M
ZNTL icon
139
Zentalis Pharmaceuticals
ZNTL
$302M
– –
-991,174
Closed -$32.4M
FUSN
140
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-187,600
Closed -$2.25M
NVTA
141
DELISTED
Invitae Corporation
NVTA
– –
-593,472
Closed -$25.7M
BRMK
142
CALL
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
– –
-2,391,536
Closed -$23.6M
QTNT
143
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-15,625
Closed -$3.21M
GBT
144
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-600,000
Closed -$33.1M
INFO
145
DELISTED
IHS Markit Ltd. Common Shares
INFO
– –
-3,812,944
Closed -$299M
NAV
146
DELISTED
Navistar International
NAV
– –
-276,600
Closed -$12M
PAND
147
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-100,000
Closed -$1.15M
MYOK
148
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-1,225,000
Closed -$167M
WMGI
149
DELISTED
Wright Medical Group Inc
WMGI
– –
-5,097,546
Closed -$156M
LVGO
150
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-830,000
Closed -$116M
3 4 5
6
7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Farallon Capital Management held 166 positions worth $16.6B, up 15% from $14.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Farallon Capital Management's Q4 2020 filing shows 39 new, 28 increased, 33 reduced and 30 closed positions. Its largest new stake was Aramark: 15,268,169 shares worth $424M. The largest sale was Immunomedics Inc, an estimated $498M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Communication Services and Financials.

  • Farallon Capital Management's largest Q4 2020 buy was Aramark: 15,268,169 shares worth $424M.
  • Farallon Capital Management added most to Willis Towers Watson in Q4 2020, an estimated $188M increase.
  • Farallon Capital Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $298M.
  • Farallon Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $498M.
  • Farallon Capital Management's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2020.
  • Farallon Capital Management opened 39 new positions and closed 30 in Q4 2020.
  • Farallon Capital Management's portfolio value rose 15% quarter-over-quarter to $16.6B.

Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.